Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin

3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D biopri...

Full description

Bibliographic Details
Main Authors: Jin Liu, Tatsuaki Tagami, Tetsuya Ozeki
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/18/6/325
_version_ 1797564632274042880
author Jin Liu
Tatsuaki Tagami
Tetsuya Ozeki
author_facet Jin Liu
Tatsuaki Tagami
Tetsuya Ozeki
author_sort Jin Liu
collection DOAJ
description 3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D bioprinter, a hydrogel-based printer ink, and UV-LED exposure. We focused on the composition of the printer ink and semi-synthesized fish gelatin methacryloyl (F-GelMA), derived from cold fish gelatin, as the main component. The low viscosity of F-GelMA due to its low melting point was remarkably improved by the addition of carboxymethyl cellulose sodium (CMC), a pharmaceutical excipient. PEGylated liposomal doxorubicin (DOX), as a model nanomedicine, was incorporated into the hydrogel and liposome stability after photo-polymerization was evaluated. The addition of CMC inhibited particle size increase. Three types of 3D-designed patches (cylinder, torus, gridlines) were produced using a 3D bioprinter. Drug release was dependent on the shape of the 3D-printed patches and UV-LED exposure time. The current study provides useful information for the preparation of 3D printed nanomedicine-based objects.
first_indexed 2024-03-10T18:59:48Z
format Article
id doaj.art-f62d21383dfb48bd98fea7812edadaea
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T18:59:48Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-f62d21383dfb48bd98fea7812edadaea2023-11-20T04:30:02ZengMDPI AGMarine Drugs1660-33972020-06-0118632510.3390/md18060325Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal DoxorubicinJin Liu0Tatsuaki Tagami1Tetsuya Ozeki2Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, JapanDrug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, JapanDrug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan3D printing technology has been applied to various fields and its medical applications are expanding. Here, we fabricated implantable 3D bio-printed hydrogel patches containing a nanomedicine as a future tailored cancer treatment. The patches were prepared using a semi-solid extrusion-type 3D bioprinter, a hydrogel-based printer ink, and UV-LED exposure. We focused on the composition of the printer ink and semi-synthesized fish gelatin methacryloyl (F-GelMA), derived from cold fish gelatin, as the main component. The low viscosity of F-GelMA due to its low melting point was remarkably improved by the addition of carboxymethyl cellulose sodium (CMC), a pharmaceutical excipient. PEGylated liposomal doxorubicin (DOX), as a model nanomedicine, was incorporated into the hydrogel and liposome stability after photo-polymerization was evaluated. The addition of CMC inhibited particle size increase. Three types of 3D-designed patches (cylinder, torus, gridlines) were produced using a 3D bioprinter. Drug release was dependent on the shape of the 3D-printed patches and UV-LED exposure time. The current study provides useful information for the preparation of 3D printed nanomedicine-based objects.https://www.mdpi.com/1660-3397/18/6/3253D bioprinterfish gelatin methacryloyl (F-GelMA)liposomenanomedicinecontrolled drug release
spellingShingle Jin Liu
Tatsuaki Tagami
Tetsuya Ozeki
Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
Marine Drugs
3D bioprinter
fish gelatin methacryloyl (F-GelMA)
liposome
nanomedicine
controlled drug release
title Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
title_full Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
title_fullStr Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
title_full_unstemmed Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
title_short Fabrication of 3D-Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local Delivery of PEGylated Liposomal Doxorubicin
title_sort fabrication of 3d printed fish gelatin based polymer hydrogel patches for local delivery of pegylated liposomal doxorubicin
topic 3D bioprinter
fish gelatin methacryloyl (F-GelMA)
liposome
nanomedicine
controlled drug release
url https://www.mdpi.com/1660-3397/18/6/325
work_keys_str_mv AT jinliu fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin
AT tatsuakitagami fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin
AT tetsuyaozeki fabricationof3dprintedfishgelatinbasedpolymerhydrogelpatchesforlocaldeliveryofpegylatedliposomaldoxorubicin